ALLMedicine Type 2 Diabetes Center

May 27th, 2020 - The two hormones responsible for the amplification of insulin secretion after oral as opposed to intravenous nutrient administration are the gut peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Howe...

May 27th, 2020 - Diabetes is the most common metabolic disease in primary health care. The prevalence and severity of diabetes can be influenced through lifestyle modification. This study was aimed to identify the prevalence of sleep disorders as a modifiable life...

May 27th, 2020 - Because other coronaviruses enter the cells by binding to dipeptidyl-peptidase-4 (DPP-4), it has been speculated that DPP-4 inhibitors (DPP-4i) may exert an activity against SARS-CoV-2. In the absence of clinical trial results, we analyzed epidemi...

May 27th, 2020 - Laparoscopic sleeve gastrectomy (LSG) is becoming a primary bariatric/metabolic surgical procedure for treating obesity and related type 2 diabetes mellitus (T2D). This study presents the long-term outcome of LSG about the remission and recurrence...

May 27th, 2020 - New-onset diabetes is an important sequela of acute pancreatitis, but there are no biomarkers to differentiate it from the much more common type 2 diabetes. The objective was to investigate whether postprandial circulating levels of gut hormones c...

Mar 2nd, 2020 - There is a general consensus that overconsumption of sugar-sweetened beverages contributes to the prevalence of obesity and related comorbidities such as type 2 diabetes (T2D). Whether a similar relationship exists for no- or low-calorie “diet” dr...

Dec 18th, 2019 - The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials...

Oct 21st, 2019 - Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp® (insulin aspart injection) 100 u/mL to include use in insulin infusion pumps for the improvement of glycemic control in adults with typ...

Oct 6th, 2019 - This joint document of the Italian Diabetes Society and the Italian Society of Nephrology reviews the natural history of diabetic kidney disease (DKD) in the light of the recent epidemiological literature and provides updated recommendations on an...

Oct 1st, 2019 - Middle-aged adults with high blood pressure, Type 2 diabetes, heart disease or stroke could be at increased risk for cancer and early death when sleeping less than 6 hours per day.

May 30th, 2020 - Glyburide and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glyburide and metformin hydrochloride tablets are a combination of glyburide, a sul...

May 27th, 2020 - The two hormones responsible for the amplification of insulin secretion after oral as opposed to intravenous nutrient administration are the gut peptides, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Howe...

May 27th, 2020 - Diabetes is the most common metabolic disease in primary health care. The prevalence and severity of diabetes can be influenced through lifestyle modification. This study was aimed to identify the prevalence of sleep disorders as a modifiable life...

May 27th, 2020 - Because other coronaviruses enter the cells by binding to dipeptidyl-peptidase-4 (DPP-4), it has been speculated that DPP-4 inhibitors (DPP-4i) may exert an activity against SARS-CoV-2. In the absence of clinical trial results, we analyzed epidemi...

May 27th, 2020 - Laparoscopic sleeve gastrectomy (LSG) is becoming a primary bariatric/metabolic surgical procedure for treating obesity and related type 2 diabetes mellitus (T2D). This study presents the long-term outcome of LSG about the remission and recurrence...

May 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The strong link between glucose control and COVID-19 outcomes has been re-affirmed in the largest study thus far of hospitalized patients with pre...

May 5th, 2020 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes "have received several serious safety warnings since approval, but the number, timeliness, and strength of these safety communications have differed between Ame...

May 4th, 2020 - Takeaway Microvascular and macrovascular diseases were frequently detected at the time of type 2 diabetes (T2D) diagnosis. Individuals with prior prediabetes were at an increased risk of microvascular disease and acute coronary syndrome at the tim...

May 3rd, 2020 - Use of the sodium-glucose cotransporter 2 (SGLT2) inhibitor diabetes drug class "may lower the risk of serious renal events in routine clinical practice," new data from a Scandinavian registry indicate. The patients, for the most part, had no kidn...

Apr 30th, 2020 - (Reuters Health) - People with nonalcoholic fatty liver disease (NAFLD) are at increased risk of developing type 2 diabetes when they consume light-to-moderate amounts of alcohol than when they abstain from drinking, a Chinese study suggests. Rese...